Cargando…
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
BACKGROUND: Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a distinctive subtype of non-small cell lung carcinoma that was not well presented in clinical studies. The management of advanced PLELC remains an important, unmet need due to the paucity of high-grade evidence. Herein, we carried ou...
Autores principales: | Zhang, Xuanye, Zhou, Yixin, Chen, Hualin, Chen, Chen, Lin, Zuan, He, Li-na, Du, Wei, Chen, Tao, Hong, Shaodong, Fu, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559223/ https://www.ncbi.nlm.nih.gov/pubmed/36248788 http://dx.doi.org/10.3389/fimmu.2022.1015444 |
Ejemplares similares
-
Emerging therapies for PBC
por: Chascsa, David Maxwell Hunter, et al.
Publicado: (2020) -
Measurement properties of the PBC-40 and PBC-27: a Dutch validation study
por: de Veer, Rozanne C, et al.
Publicado: (2021) -
Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum
por: Chen, Chen, et al.
Publicado: (2020) -
PBC technology subgroup report
por: Siemko, Andrzej, et al.
Publicado: (2018) -
Hox-PBC Partnership Demystified
por: Sedwick, Caitlin
Publicado: (2012)